Cargando…

Pathological Mechanism for Delayed Hyperenhancement of Chronic Scarred Myocardium in Contrast Agent Enhanced Magnetic Resonance Imaging

OBJECTIVES: To evaluate possible mechanism for delayed hyperenhancement of scarred myocardium by investigating the relationship of contrast agent (CA) first pass and delayed enhancement patterns with histopathological changes. MATERIALS AND METHODS: Eighteen pigs underwent 4 weeks ligation of 1 or 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jian, Xiang, Bo, Lin, Hung-Yu, Liu, Hongyu, Freed, Darren, Arora, Rakesh C., Tian, Ganghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011786/ https://www.ncbi.nlm.nih.gov/pubmed/24802515 http://dx.doi.org/10.1371/journal.pone.0096463

Ejemplares similares

Differential MR Delayed Enhancement Patterns of Chronic Myocardial Infarction between Extracellular and Intravascular Contrast Media
por: Wang, Jian, et al.
Publicado: (2015)

Concordant and Discordant Cardiac Magnetic Resonance Imaging Delayed Hyperenhancement Patterns in Patients with Ischemic and Non-Ischemic Cardiomyopathy
por: Kim, Eun Kyoung, et al.
Publicado: (2016)

Multi-contrast delayed enhancement imaging (MCDE): accuracy and reproducibility compared to conventional SSFP and delayed hyperenhancement imaging
por: Connelly, Kim A, et al.
Publicado: (2009)

Impact of delayed hyperenhancement obtained by non-contrast computed tomography following coronary angiography in patients undergoing extracorporeal cardiopulmonary resuscitation
por: Watanabe, Tomomi, et al.
Publicado: (2020)

Quantitative assessment of pericardial delayed hyperenhancement helps identify patients with ongoing recurrences of pericarditis
por: Kumar, Arnav, et al.
Publicado: (2018)

Myocardium area at risk measured with delayed enhancement after scar remodelling compared with T2-weighted cardiac magnetic resonance imaging
por: Lønborg, Jacob T, et al.
Publicado: (2011)

The decisive role of cardiovascular MRI delayed hyperenhancement (DHE) pattern for risk stratification for dilated cardiomyopathy
por: Venero, Jose V, et al.
Publicado: (2009)

Inhibition of Viability, Proliferation, Cytokines Secretion, Surface Antigen Expression, and Adipogenic and Osteogenic Differentiation of Adipose-Derived Stem Cells by Seven-Day Exposure to 0.5 T Static Magnetic Fields
por: Wang, Jian, et al.
Publicado: (2016)

Characterizing Computed Tomography-Detected Arterial Hyperenhancing-Only Lesions in Patients at Risk of Hepatocellular Carcinoma: Can Non-Contrast Magnetic Resonance Imaging Be Used for Sequential Imaging?
por: Park, So Hyun, et al.
Publicado: (2020)

A case report of a myocardial ischaemic attack: a novel hyperenhancement pattern on cardiac magnetic resonance in focal ischaemic injury
por: Nies, Hedwig M J M, et al.
Publicado: (2023)

Corrigendum to “Preservation of Myocardial Perfusion and Function by Keeping Hypertrophied Heart Empty and Beating for Valve Surgery: An In Vivo MR Study of Pig Hearts”
por: Wang, Jian, et al.
Publicado: (2017)

Preservation of Myocardial Perfusion and Function by Keeping Hypertrophied Heart Empty and Beating for Valve Surgery: An In Vivo MR Study of Pig Hearts
por: Wang, Jian, et al.
Publicado: (2017)

Prevalence of scarred and dysfunctional myocardium in patients with heart failure of ischaemic origin: A cardiovascular magnetic resonance study
por: Bourantas, Christos V, et al.
Publicado: (2011)

Dispersion of hyperenhancement in late gadolinium enhancement cardiovascular magnetic resonance measured with Moran's I is associated with a decrement in LVEF 6 months after cardiotoxic chemotherapy
por: Jordan, Jennifer H, et al.
Publicado: (2013)

Contrast agents in dynamic contrast-enhanced magnetic resonance imaging
por: Yan, Yuling, et al.
Publicado: (2017)

Theranostics and contrast agents for magnetic resonance imaging
por: Jeong, Yohan, et al.
Publicado: (2018)

Magnetic Resonance Neuroimaging Contrast Agents of Nanomaterials
por: Guo, Longjun, et al.
Publicado: (2022)

Identification of Arterial Hyperenhancement in CT and MRI in Patients with Hepatocellular Carcinoma: Value of Unenhanced Images
por: Kim, Mimi, et al.
Publicado: (2019)

Dynamically switchable magnetic resonance imaging contrast agents
por: Wang, Qiyue, et al.
Publicado: (2021)

Contrast Agents of Magnetic Resonance Imaging and Future Perspective
por: Lv, Jie, et al.
Publicado: (2023)

Retracted: Magnetic Resonance Neuroimaging Contrast Agents of Nanomaterials
por: International, BioMed Research
Publicado: (2023)

Evaluation of Microbubbles as Contrast Agents for Ultrasonography and Magnetic Resonance Imaging
por: Li, Ling, et al.
Publicado: (2012)

Activatable T(1) and T(2) Magnetic Resonance Imaging Contrast Agents
por: Tu, Chuqiao, et al.
Publicado: (2011)

Use of contrast agents in oncological imaging: magnetic resonance imaging
por: Morana, Giovanni, et al.
Publicado: (2013)

Nanoparticle-Based Paramagnetic Contrast Agents for Magnetic Resonance Imaging
por: Pellico, Juan, et al.
Publicado: (2019)

Differentiation of Recently Infarcted Myocardium from Chronic Myocardial Scar: The Value of Contrast-Enhanced SSFP-Based Cine MR Imaging
por: Kim, Kyoung Ah, et al.
Publicado: (2006)

Automatic segmentation of myocardium at risk in T2-weighted cardiovascular magnetic resonance
por: Sjogren, Jane, et al.
Publicado: (2012)

Temporal dystrophic remodeling within the intrinsic cardiac nervous system of the streptozotocin-induced diabetic rat model
por: Menard, Chantalle E, et al.
Publicado: (2014)

Myocardium at risk by magnetic resonance imaging: head-to-head comparison of T2-weighted imaging and contrast-enhanced steady-state free precession
por: Ubachs, Joey F.A., et al.
Publicado: (2012)

The role of cardiac magnetic resonance non-contrast T1 mapping in differentiation between injured and salvaged myocardium in acute and chronic myocardial infarction
por: Urbańczyk-Zawadzka, Małgorzata, et al.
Publicado: (2022)

Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
por: Estelrich, Joan, et al.
Publicado: (2015)

Surface impact on nanoparticle-based magnetic resonance imaging contrast agents
por: Zhang, Weizhong, et al.
Publicado: (2018)

Radiographic and magnetic resonances contrast agents: Essentials and tips for safe practices
por: Nouh, Mohamed R, et al.
Publicado: (2017)

Gd-Si Oxide Nanoparticles as Contrast Agents in Magnetic Resonance Imaging
por: Cabrera-García, Alejandro, et al.
Publicado: (2016)

Synthesis and Comparative Evaluation of Photoswitchable Magnetic Resonance Imaging Contrast Agents
por: Gao, Mingchun, et al.
Publicado: (2020)

Advances in magnetic resonance imaging contrast agents for glioblastoma-targeting theranostics
por: Wu, Zijun, et al.
Publicado: (2021)

Formation of gadolinium–ferritin from clinical magnetic resonance contrast agents
por: Neburkova, Jitka, et al.
Publicado: (2020)

Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma
por: Zhuang, Danping, et al.
Publicado: (2022)

A Comprehensive Introduction to Magnetic Resonance Imaging Relaxometry and Contrast Agents
por: Alzola-Aldamizetxebarria, Saioa, et al.
Publicado: (2022)

Cell sorting microbeads as novel contrast agent for magnetic resonance imaging
por: Khurana, Aman, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g82omq924dtd77t9bso4eq1sca